1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Dahiyat, B.I.
Sarisky, C.A.
Mayo, S.L.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
273
789
796
10.1006/jmbi.1997.1341
9367772
De novo protein design: towards fully automated sequence selection.
1997
US
Science
SCIEAS
0038
0036-8075
278
82
De Novo Protein Design: Fully Automated Sequence Selection
1997
10.2210/pdb1psv/pdb
pdb_00001psv
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
DESIGNED PEPTIDE
3368.819
PDA8D
1
syn
polymer
no
no
KPYTARIKGRTFSNEKELRDFLETFTGR
KPYTARIKGRTFSNEKELRDFLETFTGR
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1998-01-28
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-03-02
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1997-10-29
REL
SEQUENCE SELECTED BY DEAD END ELIMINATION
sample
NO RESTRAINT VIOLATIONS GREATER THAN 0.3 ANGSTROMS, RMS DEVIATIONS FROM IDEALIZED BOND LENGTHS < 0.01 A, AND RMS DEVIATIONS FROM IDEALIZED ANGLES AND IMPROPERS < 1.0 DEGREE
98
32
NOESY
TOCSY
DQF-COSY
5.0
280
K
SEE JRNL CITATION ABOVE.
HYBRID DISTANCE GEOMETRY-SIMULATED ANNEALING
BRUNGER
refinement
X-PLOR
structure solution
ANSIG
structure solution
X-PLOR
600
Varian
UNITYPLUS 600
LYS
1
n
1
LYS
1
A
PRO
2
n
2
PRO
2
A
TYR
3
n
3
TYR
3
A
THR
4
n
4
THR
4
A
ALA
5
n
5
ALA
5
A
ARG
6
n
6
ARG
6
A
ILE
7
n
7
ILE
7
A
LYS
8
n
8
LYS
8
A
GLY
9
n
9
GLY
9
A
ARG
10
n
10
ARG
10
A
THR
11
n
11
THR
11
A
PHE
12
n
12
PHE
12
A
SER
13
n
13
SER
13
A
ASN
14
n
14
ASN
14
A
GLU
15
n
15
GLU
15
A
LYS
16
n
16
LYS
16
A
GLU
17
n
17
GLU
17
A
LEU
18
n
18
LEU
18
A
ARG
19
n
19
ARG
19
A
ASP
20
n
20
ASP
20
A
PHE
21
n
21
PHE
21
A
LEU
22
n
22
LEU
22
A
GLU
23
n
23
GLU
23
A
THR
24
n
24
THR
24
A
PHE
25
n
25
PHE
25
A
THR
26
n
26
THR
26
A
GLY
27
n
27
GLY
27
A
ARG
28
n
28
ARG
28
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
10
A
A
O
H
LEU
LEU
18
22
1.60
15
A
A
O
H
LEU
LEU
18
22
1.51
16
A
A
O
H
LEU
LEU
18
22
1.46
18
A
A
O
H
LEU
LEU
18
22
1.55
19
A
A
O
H
LEU
LEU
18
22
1.59
20
A
A
O
H
LEU
LEU
18
22
1.51
21
A
A
O
H
LEU
LEU
18
22
1.43
22
A
A
O
H
LEU
LEU
18
22
1.43
23
A
A
O
H
LEU
LEU
18
22
1.47
25
A
A
O
H
LEU
LEU
18
22
1.49
26
A
A
O
H
LEU
LEU
18
22
1.46
27
A
A
O
H
ILE
GLY
7
9
1.58
28
A
A
O
H
LEU
LEU
18
22
1.53
29
A
A
O
H
LEU
LEU
18
22
1.47
31
A
A
O
H
LEU
LEU
18
22
1.40
32
A
A
O
H
LEU
LEU
18
22
1.40
1
A
THR
4
-167.39
64.86
1
A
LYS
8
-159.65
10.66
1
A
THR
11
64.87
149.64
1
A
THR
24
-97.46
46.57
2
A
TYR
3
-60.82
-176.04
2
A
THR
4
-170.23
-50.25
2
A
ALA
5
63.69
132.11
2
A
LYS
8
-161.04
8.89
2
A
THR
11
65.71
146.80
2
A
THR
24
-98.03
44.98
3
A
THR
4
-155.90
70.38
3
A
LYS
8
-157.45
9.28
3
A
THR
11
65.34
148.09
3
A
THR
24
-94.10
44.63
4
A
TYR
3
-63.82
-179.48
4
A
THR
4
-171.89
-47.40
4
A
ALA
5
64.22
132.47
4
A
LYS
8
-160.17
8.30
4
A
THR
11
65.45
146.84
4
A
THR
24
-96.93
47.26
5
A
THR
4
-168.46
-51.21
5
A
ALA
5
61.74
133.88
5
A
THR
11
65.06
148.48
5
A
THR
24
-98.49
47.83
5
A
PHE
25
-142.92
-46.58
6
A
THR
4
-161.53
-50.77
6
A
ALA
5
63.90
135.77
6
A
ILE
7
-120.65
-67.10
6
A
LYS
8
-143.45
10.89
6
A
THR
11
64.70
150.10
6
A
THR
24
-97.36
48.54
6
A
PHE
25
-137.69
-45.68
7
A
THR
4
-174.44
70.93
7
A
LYS
8
-145.05
-0.81
7
A
THR
11
83.36
-23.25
7
A
PHE
12
53.15
116.32
7
A
THR
24
-100.68
46.85
7
A
THR
26
-146.81
31.65
8
A
THR
4
-158.30
75.84
8
A
LYS
8
-156.34
7.12
8
A
THR
11
64.68
129.79
8
A
THR
24
-101.86
44.94
9
A
THR
4
-155.25
72.30
9
A
ILE
7
-120.74
-64.39
9
A
LYS
8
-144.65
10.02
9
A
THR
11
64.84
152.09
9
A
THR
24
-99.47
43.98
9
A
PHE
25
-145.52
28.44
10
A
THR
11
64.24
149.00
10
A
THR
24
-97.96
45.80
10
A
PHE
25
-151.95
-46.98
11
A
PRO
2
-72.59
-167.50
11
A
THR
4
-156.89
76.77
11
A
LYS
8
-174.15
-32.67
11
A
THR
11
65.19
130.82
11
A
THR
24
-99.77
43.41
12
A
THR
4
-173.83
72.24
12
A
ALA
5
-47.27
163.80
12
A
ARG
6
-92.16
41.70
12
A
LYS
8
-155.80
9.72
12
A
THR
11
82.75
-28.13
12
A
PHE
12
54.12
116.60
12
A
THR
24
-99.98
46.21
12
A
PHE
25
-158.87
35.59
13
A
THR
4
-170.61
-38.98
13
A
ALA
5
59.98
153.64
13
A
ARG
6
-89.69
46.02
13
A
LYS
8
-158.47
9.99
13
A
THR
11
83.25
-36.14
13
A
PHE
12
53.50
111.55
13
A
THR
24
-98.44
47.61
13
A
PHE
25
-130.96
-55.95
14
A
THR
4
-158.38
73.07
14
A
LYS
8
-152.68
6.30
14
A
THR
11
65.03
149.64
14
A
THR
24
-104.91
46.24
14
A
THR
26
-142.97
38.23
15
A
TYR
3
-56.89
173.94
15
A
THR
4
-172.73
63.59
15
A
ARG
6
-69.69
69.65
15
A
ILE
7
-125.22
-65.95
15
A
LYS
8
-141.15
10.15
15
A
THR
11
90.84
-37.48
15
A
PHE
12
54.07
168.59
15
A
THR
24
-98.10
47.41
15
A
PHE
25
-138.90
-46.37
16
A
THR
4
-173.78
67.69
16
A
ALA
5
-45.09
158.46
16
A
ARG
6
-86.63
46.85
16
A
LYS
8
-156.76
9.78
16
A
THR
11
80.31
-34.90
16
A
PHE
12
54.49
111.44
16
A
THR
24
-97.37
48.76
16
A
PHE
25
-148.60
-55.15
17
A
TYR
3
-59.89
176.89
17
A
THR
4
-172.29
62.97
17
A
LYS
8
-156.89
8.85
17
A
THR
11
90.15
-37.99
17
A
PHE
12
48.93
101.62
17
A
THR
24
-96.68
45.35
18
A
THR
4
-171.01
-32.49
18
A
ALA
5
64.22
148.58
18
A
ILE
7
-137.22
-147.45
18
A
THR
11
84.23
-34.28
18
A
PHE
12
53.64
110.13
18
A
THR
24
-97.71
47.38
19
A
TYR
3
-56.82
-179.12
19
A
THR
4
-164.63
-38.91
19
A
ALA
5
60.24
160.87
19
A
LYS
8
57.55
-61.53
19
A
THR
11
64.64
153.80
19
A
THR
24
-96.98
47.83
19
A
PHE
25
-146.02
-55.56
20
A
TYR
3
-59.24
174.27
20
A
THR
4
-172.01
-38.13
20
A
ALA
5
62.33
152.10
20
A
ILE
7
-129.93
-143.93
20
A
THR
11
65.22
145.72
20
A
THR
24
-98.66
47.16
20
A
PHE
25
-152.72
-54.24
21
A
LYS
8
-159.98
8.67
21
A
THR
11
64.78
148.88
21
A
THR
24
-98.13
48.41
21
A
PHE
25
-147.45
-59.11
22
A
THR
4
-175.89
66.76
22
A
ALA
5
-45.84
159.35
22
A
ARG
6
-87.03
47.06
22
A
LYS
8
-156.89
10.11
22
A
THR
11
81.01
-35.91
22
A
PHE
12
54.36
113.70
22
A
THR
24
-99.17
47.17
22
A
PHE
25
-157.71
34.30
23
A
PRO
2
-71.08
-87.16
23
A
THR
4
-176.17
68.53
23
A
LYS
8
-157.42
9.53
23
A
THR
11
81.13
-35.34
23
A
PHE
12
54.66
114.63
23
A
THR
24
-96.97
49.87
23
A
PHE
25
-131.36
-49.24
24
A
THR
4
-176.66
69.97
24
A
LYS
8
-171.07
-37.83
24
A
THR
11
82.37
-30.78
24
A
PHE
12
53.57
113.40
24
A
THR
24
-103.01
43.12
25
A
THR
4
-170.53
-41.18
25
A
ALA
5
63.34
135.12
25
A
LYS
8
-173.65
-36.09
25
A
THR
11
82.96
-36.85
25
A
PHE
12
54.27
109.27
25
A
THR
24
-98.75
47.11
25
A
PHE
25
-154.78
-60.68
26
A
ALA
5
53.40
-177.11
26
A
ARG
6
-97.76
38.85
26
A
ILE
7
-123.90
-150.41
26
A
THR
11
83.97
-39.62
26
A
PHE
12
54.90
117.22
26
A
THR
24
-99.67
45.46
26
A
PHE
25
-159.15
37.16
27
A
THR
4
-161.78
72.82
27
A
LYS
8
54.95
-60.58
27
A
THR
11
64.22
158.62
27
A
THR
24
-96.96
38.76
28
A
TYR
3
-63.66
-175.80
28
A
THR
4
-175.15
-26.56
28
A
ALA
5
64.30
151.19
28
A
LYS
8
52.95
-81.16
28
A
THR
11
82.32
-36.39
28
A
PHE
12
49.46
102.29
28
A
THR
26
-154.53
29.03
29
A
THR
4
-172.90
81.86
29
A
ALA
5
-45.80
170.41
29
A
LYS
8
59.81
-60.54
29
A
THR
11
82.43
-15.16
29
A
PHE
12
43.42
108.68
29
A
ASN
14
-172.69
-164.28
29
A
THR
24
-98.92
48.47
29
A
PHE
25
-147.37
-50.88
30
A
TYR
3
-63.87
-177.95
30
A
THR
4
-174.07
-31.71
30
A
ALA
5
63.78
159.98
30
A
ARG
6
-86.10
44.70
30
A
ILE
7
-125.35
-144.32
30
A
THR
11
86.60
-35.61
30
A
PHE
12
48.84
100.75
31
A
THR
4
-174.46
76.45
31
A
ALA
5
-47.23
159.99
31
A
LYS
8
63.78
-55.12
31
A
THR
11
84.01
-20.27
31
A
PHE
12
51.63
112.03
31
A
LEU
22
-39.09
-32.32
31
A
THR
24
-101.41
58.55
31
A
PHE
25
-136.25
-43.70
32
A
THR
4
179.84
-42.11
32
A
ALA
5
64.24
139.86
32
A
LYS
8
64.10
-62.94
32
A
THR
11
65.66
142.34
32
A
SER
13
-26.77
-42.40
32
A
THR
24
-100.46
40.61
32
A
THR
26
-153.46
43.75
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
COMPUTATIONALLY DESIGNED PEPTIDE WITH A BETA-BETA-ALPHA FOLD SELECTION, NMR, 32 STRUCTURES
1
Y
N
A
GLU
15
A
GLU
15
HELX_P
A
GLU
23
A
GLU
23
1
1
9
DESIGNED PEPTIDE
PROTEIN DESIGN, DEAD END ELIMINATION, BETA-BETA-ALPHA FOLD, SEQUENCE OPTIMIZATION, DESIGNED PEPTIDE
1PSV
PDB
1
1PSV
1
28
1PSV
1
28
1PSV
A
1
1
28
1
P 1